Jun joined the Cancer Research Institute in January 2017 as a senior research analyst in the Clinical Accelerator program. Since July 2018, he has been the Senior Manager of Clinical Accelerator and leading the diligence research, academic publication, and consulting services of the Clinical Accelerator program.
Prior to CRI, Jun spent more than a decade as a scientist in immunology and biomedical engineering. He received his bachelor's degree in bioengineering in 2005 and a master degree in biochemistry in 2008 in China. He continued graduate study in the U.S. and received his Ph.D. in 2014 from Icahn School of Medicine at Mount Sinai, where he developed nanomaterial-based immunotherapies for cardiovascular diseases and cancer. He completed a postdoctoral fellowship at Memorial Sloan Kettering Cancer Center in 2017, where he developed cancer immunotherapies for solid tumors and imaging probes for PET imaging. Jun has published 33 peer-reviewed papers, given 12 conference presentations, won eight research awards, and filed one patent.
Jun strongly believes that cancer immunotherapy will revolutionize cancer treatment and save millions of lives.
- Tang J, Hubbard-Lucey VM, Pearce L, O’Donnell-Tormey J, Shalabi A. The global landscape of cancer cell therapy. Nature Reviews Drug Discovery. 10.1038/nrd.2018.74 (2018)
- Tang J, Shalabi A, Hubbard-Lucey VM. Comprehensive analysis of the clinical immuno-oncology landscape. Ann Oncol. 2017 Dec 7. doi: 10.1093/annonc/mdx755. [Epub ahead of print]
- Tang J, Salloum D, Carney B, et al. Targeted PET imaging strategy to differentiate malignant from inflamed lymph nodes in diffuse large B-cell lymphoma. Proc Natl Acad Sci USA 114 E7441-7449 (2017).
- Hogstad B*, Berres M*, Chakraborty R*, Tang J, et al. RAF/MEK/ERK pathway suppresses dendritic cell migration and traps dendritic cells in LCH lesions. J Exp Med, In Press, (2017).
- Tang J, Baxter S, Menon A, et al., Immune cell screening of a nanoparticle library improves atherosclerosis therapy. Proc Natl Acad Sci USA 113, E6731-E6740 (2016).
- Perez-Medina C, Abdel-Atti D, Tang J, et al., Nanoreporter PET predicts the efficacy of anti-cancer nanotherapy. Nature communications 7, 11838 (2016).
- Tang J, Lobatto ME, Hassing L, et al., Inhibiting macrophage proliferation suppresses atherosclerotic plaque inflammation. Science Advances 1, (2015).
- Perez-Medina C, Tang J, Abdel-Atti D, et al., PET Imaging of Tumor-Associated Macrophages with 89Zr-Labeled High-Density Lipoprotein Nanoparticles. J Nucl Med 56, 1272-1277 (2015).
- Duivenvoorden R*, Tang J*, Cormode DP, et al., A statin-loaded reconstituted high-density lipoprotein nanoparticle inhibits atherosclerotic plaque inflammation. Nature Communications 5, 3065 (2014).
- Gianella A, Jarzyna PA, Mani V, Ramachandran S, Calcagno C, Tang J, et al., Multifunctional nanoemulsion platform for imaging guided therapy evaluated in experimental cancer. ACS Nano 5, 4422-4433 (2011).
Let's spread the word about Immunotherapy! Click to share this page with your community.